Related Experiment Video
Updated: Jun 3, 2026

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
Efficacy of endoscopic therapy for gastrointestinal bleeding from Dieulafoy's lesion
Jun Cui1, Liu-Ye Huang, Yun-Xiang Liu
1Department of Gastroenterology, Yantai Yu Huang Ding Hospital, Yantai, Shandong Province, China.
Insights
Endoscopic hemostasis for Dieulafoy
Area of Science:
- Gastroenterology
- Endoscopy
- Surgical Innovation
Background:
- Dieulafoy's lesion is a rare but significant cause of gastrointestinal bleeding.
- Effective endoscopic hemostasis is crucial for managing this condition.
Purpose of the Study:
- To compare the efficacy of three endoscopic hemostasis techniques for Dieulafoy's lesion.
- To identify the most effective treatment strategy.
Main Methods:
- A study involving 107 patients with gastrointestinal bleeding due to Dieulafoy's lesion.
- Comparison of aethoxysklerol injection, hemoclip hemostasis, and a combination therapy.
- Evaluation of successful hemostasis rates and complications.
Main Results:
- The combined therapy achieved a 96.7% success rate, significantly higher than aethoxysklerol injection (71.7%) or hemoclip hemostasis alone (77.4%).
- No serious complications like perforation were observed.
- No re-bleeding occurred during the 1-year follow-up period.
Conclusions:
- Combined hemoclip hemostasis with aethoxysklerol injection is the most effective endoscopic treatment for Dieulafoy's lesion.
- This combination offers a safe and highly successful approach to managing bleeding from Dieulafoy's lesions.
Aim:
To investigate the endoscopic hemostasis for gastrointestinal bleeding due to Dieulafoy's lesion.
Methods:
One hundred and seven patients with gastrointestinal bleeding due to Dieulafoy's lesion were treated with three endoscopic hemostasis methods: aethoxysklerol injection (46 cases), endoscopic hemoclip hemostasis (31 cases), and a combination of hemoclip hemostasis with aethoxysklerol injection (30 cases).
Results:
The rates of successful hemostasis using the three methods were 71.7% (33/46), 77.4% (24/31) and 96.7% (29/30), respectively, with significant differences between the methods (P < 0.05). Among those who had unsuccessful treatment with aethoxysklerol injection, 13 were treated with hemoclip hemostasis and 4 underwent surgical operation; 9 cases were successful in the injection therapy. Among the cases with unsuccessful treatment with hemoclip hemostasis, 7 were treated with injection of aethoxysklerol and 3 cases underwent surgical operation; 4 cases were successful in the treatment with hemoclip hemostasis. Only 1 case had unsuccessful treatment with a combined therapy of hemoclip hemostasis and aethoxysklerol injection, and surgery was then performed. No serious complications of perforation occurred in the patients whose bleeding was treated with the endoscopic hemostasis, and no re-bleeding was found during a 1-year follow-up.
Conclusion:
The combined therapy of hemoclip hemostasis with aethoxysklerol injection is the most effective method for gastrointestinal bleeding due to Dieulafoy's lesion.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Endoscopic Procedures V: ERCP
Patient...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
